Leader Maximum Strength Mucus Relief provides targeted expectorant therapy with 1200 mg of Guaifenesin per extended-release tablet. This 14-count supply delivers 12-hour continuous action, enabling efficient mucus mobilization and airway clearance with minimal dosing frequency. The advanced formulation works to thin and liquefy respiratory secretions, promoting productive coughing and reducing chest congestion associated with colds, flu, and bronchial irritation. Engineered for sustained therapeutic efficacy, a single daily dose maintains uninterrupted respiratory support throughout waking or sleeping hours. This maximum-strength option represents an evidence-based choice for individuals managing persistent mucus accumulation and seeking extended symptom control without repeated medication administration.